BUZZ-Neuphoria Therapeutics rises on $15 mln milestone payment from Merck
Massachusetts-based drug developer Neuphoria Therapeutics NEUP.O rises 3.31% to $4.65 in morning trade
Co, which develops treatments for brain and mental health disorders, says it is due to receive $15 million milestone payment from Merck MRK.N
The payment is triggered by the start of a mid-stage study for the treatment of Merck's Alzheimer's disease dementia
The study is estimated to complete on July 20, 2027
The study is to test if the experimental drug, MK-1167, given along with another therapy that affects memory, which can improve symptoms of Alzheimer's disease dementia such as memory and mental activity
NEUP is eligible to receive up to $450 million in additional milestone payments if certain developments are achieved
In the last 12 months, the stock down 70%
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
Is Bitcoin’s Four-Year Cycle Dead in 2026?
Is the Bitcoin 4-year cycle dead? After 2025 broke historical records with a red post-halving year, institutional analysts explore if the Bitcoin price has decoupled from the halving countdown. Analyze the impact of spot ETFs, global liquidity, and the roadmap to the 2028 halving in this 2026 market
